A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster

Molecular and Cellular Neuroscience

Volumn 26, Issue 3, 2004, Pages 365-375

  Finelli, Alyce ^a   Kelkar, Anju ^a   Song, Ho Juhn ^a   Yang, Haidi ^a   Konsolaki, Mary ^a,b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; MEMBRANE METALLOENDOPEPTIDASE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; GENE MUTATION; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; NEPRILYSIN; PEPTIDE FRAGMENTS; PHENOTYPE;

DROSOPHILA MELANOGASTER; MELANOGASTER;

EID: 3242809725     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2004.03.001     Document Type: Article

References (74)

1. Anderton B.H., Dayanandan R., Killick R., Lovestone S. Does the dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease. Mol. Med. Today. 6:2000;54-59
2. Annaert W.G., et al. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J. Cell Biol. 147:1999;277-294
3. Ashburner M. Tissue culture. Drosophila - A Laboratory Handbook. 1989;128-132 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
4. Auluck P.K., Chan H.Y., Trojanowski J.Q., Lee V.M.Y., Bonini N.M. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 295:2002;865-868
5. Barnes K., Doherty S., Turner A.J. Endopeptidase-24.11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus. J. Neurochem. 64:1995;1826-1832
6. Boulianne G.L., Livne-Bar I., Humphreys J.M., Liang Y., Lim C., Rogaev E., St. George-Hyslop P. Cloning and characterization of the Drosophila presenilin homologue. NeuroReport. 8:1997;1025-1029
7. Brand A.H., Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 118:1993;401-415
8. Brewer G.J. Age-related toxicity to lactate, glutamate, and beta-amyloid in cultured adult neurons. Neurobiol. Aging. 19:1998;561-568
9. Cagan R.L., Ready D.F. Notch is required for successive cell decisions in the developing Drosophila retina. Genes Dev. 3:1989;1099-1112
10. Carson J.A., Turner A.J. β-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J. Neurochem. 81:2002;1-8
11. Cescato R., Dumermuth E., Spiess M., Paganetti P. Increased generation of alternatively cleaved beta-amyloid peptides in cells expressing mutants of the amyloid precursor protein defective in endocytosis. J. Neurochem. 74:2000;1131-1139
12. Chen M., Fernandez H.L. Where do Alzheimer's plaques and tangles come from? Aging-induced protein degradation inefficiency. Front. Biosci. 6:2001;e1-e11
13. Citron M., Teplow D.B., Selkoe D.J. Generation of amyloid β protein from its precursor is sequence specific. Neuron. 14:1995;661-670
14. De Strooper B. Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex. Neuron. 38:2003;9-12
15. Engels W.R. A trans-acting product needed for P factor transposition in Drosophila. Science. 226:1984;1194-1196
16. Feany M.B., Bender W.W. A Drosophila model of Parkinson's disease. Nature. 404:2000;394-398
17. Fernandez-Funez P., et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 408:2000;101-106
18. Fossgreen A., Bruckner B., Czech C., Masters C.L., Beyreuther K., Paro R. Transgenic Drosophila expressing human amyloid precursor protein show γ-secretase activity and a blistered-wing phenotype. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13703-13708
19. Giovannelli L., Scali C., Faussone-Pellegrini M.S., Pepeu G., Casamenti F. Long-term changes in the aggregation state and toxic effects of β-amyloid injected into the rat brain. Neuroscience. 87:1998;349-357
20. Halder G., Patrick C., Flister S., Walldorf U., Kloter U., Gehring W.J. Eyeless initiates the expression of both sine oculis and eyes absent during Drosophila compound eye development. Development. 125:1998;2181-2191
21. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Jr. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem. Biol. 4:1997;119-125
22. Hay B.A., Wolff T., Rubin G.M. Expression of baculovirus P35 prevents cell death in Drosophila. Development. 120:1994;2121-2129
23. Hay B.A., Maile R., Rubin G.M. P element insertion-dependent gene activation in the Drosophila eye. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5195-5200
24. Heidary G., Fortini M.E. Identification and characterization of the Drosophila tau homolog. Mech. Dev. 108:2001;171-178
25. Hyman B.T., Strickland D., Rebeck G.W. Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease. Arch. Neurol. 57:2000;646-650
26. Iwata N., et al. Metabolic regulation of brain Abeta by neprilysin. Science. 292:2001;1550-1552
27. Jackson G.R., Salecker I., Dong X., Yao X., Arnheim N., Faber P.W., MacDonald M.E., Zipursky S.L. Polyglutamine-expanded human Huntington transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron. 21:1998;633-642
28. Jackson J.R., Wiedau-Pazos M., Sang T.K., Wagle N., Brown C.A., Massachi S., Geschwind D.H. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron. 34:2002;509-519
29. Jarrett J.T., Lansbury P.T. Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 73:1983;1055-1058
30. Jarrett J.T., Berger E.P., Lansbury P.T. Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697
31. Kazemi-Esfarjani P., Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science. 287:2000;1837-1840
32. Kellum R., Schedl P. A position-effect assay for boundaries of higher order chromosomal domains. Cell. 64:1991;941-950
33. Kurochkin I.V. Insulin-degrading enzyme: embarking on amyloid destruction. TIBS. 26:2001;421-425
34. LaFerla F.M., Tinkle B.T., Bieberich C.J., Haudenschild C.C., Jay G. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:1995;21-30
35. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., Frosch M.P., Selkoe D.J. Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron. 40:2003;1087-1093
36. Li C., Hersh L.B. Neprilysin: assay methods, purification, and characterization. Methods Enzymol. 248:1995;253-263
37. Lin D.M., Goodman C.S. Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron. 13:1994;507-523
38. Link C.D. Expression of human β-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9368-9372
39. Lorenzo A., Yankner B.A. Beta amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U. S. A. 91:1994;12243-12247
40. Manni M.E., Cescato R., Paganetti P.A. Lack of β-amyloid production in M19 cells deficient in site 2 processing of the sterol regulatory element binding proteins. FEBS Lett. 427:1998;367-370
41. Marr R.A., Rockenstein E., Mukherjee A., Kindy M.S., Hersh L.B., Gage F.H., Verma I.M., Masliah E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23:2003;1992-1996
42. McKee A.C., Kowall N.W., Schumacher J.S., Beal M.F. The neurotoxicity of amyloid beta protein in aged primates. Amyloid. 5:1998;1-9
43. Min K.-T., Benzer S. Preventing neurodegeneration in the Drosophila mutant bubblegum. Science. 284:1999;1985-1988
44. Moses K., Ellis M.C., Rubin G.M. The glass gene encodes a zinc-finger protein required by Drosophila photoreceptor cells. Nature. 340:1989;531-536
45. Mukherjee A., Song E., Kihiko-Ehmann M., Goodman J.P. Jr., Pyrek J.S., Estus S., Hersh L.B. Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J. Neurosci. 20:2000;8745-8749
46. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 283:2000;1571-1577
47. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687
48. Poirier J. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann. N. Y. Acad. Sci. 924:2000;81-90
49. Pradier L., et al. Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction. Neurobiol. Dis. 6:1999;43-55
50. Robertson H.M., Preston C.R., Phillis R.W., Johnson-Schlitz D., Benz W.K., Engels W.R. A stable genomic source of P element transposase in Drosophila melanogaster. Genetics. 118:1988;461-470
51. Rorth P. A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Proc. Natl. Acad. Sci. U. S. A. 93:1996;12418-12422
52. Rorth P., et al. Systematic gain-of-function genetics in Drosophila. Development. 125:1998;1049-1057
53. Rosen D.R., Martin-Morris L., Luo L., White C. A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2478-2482
54. Rubin G.M., Spradling A.C. Genetic transformation of Drosophila with transposable element vectors. Science. 218:1982;348-353
55. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron. 32:2001;177-180
56. Sinha S., et al. Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature. 402:1999;537-540
57. Spradling A.C., Rubin G.M. The effect of chromosomal position on the expression of the Drosophila xanthine dehydrogenase gene. Cell. 34:1983;47-57
58. Steffan J.S., et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 413:2001;739-743
59. Sudoh S., Frosch M.P., Wolf B.A. Differential effects of proteases involved in intracellular degradation of amyloid beta-protein between detergent-soluble and -insoluble pools in CHO-695 cells. Biochemistry. 41:2002;1091-1099
60. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos L., Eckman C., Golde T.E., Younkin S.G. An increased percentage of long amyloid-β protein secreted by familial amyloid-β protein precursor (β-APP(717)) mutants. Science. 264:1994;1336-1340
61. Tamaoka A., Sawamura N., Odaka A., Suzuki N., Mizusawa H., Shoji S., Mori H. Amyloid beta protein 1-42/43 (A beta 1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study. Brain Res. 679:1995;151-156
62. Tariot P., Winblat B. Therapeutics and therapeutic strategies. Iqbal K., Sisodia A.S., Winblad B. Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics. 2001;707-723 Wiley, New York
63. Tucker H.M., et al. The plasmin system is induced by and degrades amyloid-beta aggregates. J. Neurosci. 20:2000;3937-3946
64. Turner R.S., Suzuki N., Chung A.S., Younkin S.G., Lee V.M. Amyloids beta40 and beta42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J. Biol. Chem. 271:1996;8966-8970
65. Turner A.J., Isaac R.E., Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. BioEssays. 23:2001;261-269
66. Vassar R., et al. β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286:1999;735-741
67. Vekrellis K., Ye Z., Qui W.Q., Walsh D., Hartley D., Chesneau V., Rosner M.R., Selkoe D.J. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J. Neurosci. 20:2000;1657-1665
68. Wals D.M., Klyubin I., Fadeeva J.V., Rowan M.J., Selkoe D.J. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30:2002;552-557
69. Warrick J.M., Chan H.Y., Gray-Board G.L., Chai Y., Paulson H.L., Bonini N.M. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23:1999;425-428
70. Wittmann C.W., Wszolek M.F., Shulman J.M., Salvaterra P.M., Lewis J., Hutton M., Feany M.B. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science. 293:2001;711-714
71. Wolff T. Histological techniques for the Drosophila eye Part I and II. Sullivan W., Ashburner M., Hawley R.S. Drosophila Protocols. 2000;201-241 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
72. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., Masliah E., Mucke L. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7:2001;612-618
73. Yan R., et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature. 402:1999;533-537
74. Ye Y., Fortini M. Apoptotic activities of wild-type and Alzheimer's disease-related mutant presenilins in Drosophila melanogaster. J. Cell Biol. 146:1999;1351-1364